MedPath

FMF and Atheroscelerosis

Not yet recruiting
Conditions
FMF
Registration Number
NCT06047938
Lead Sponsor
Assiut University
Brief Summary

The aim of this study is to search for subclinical atherosclerosis in children diagnosed as FMF in Assiut University children's Hospital, and to correlate the risk to develop atherosclerosis to the different characters and genetic variants of FMF.

Detailed Description

* To describe the clinical characteristics of patients diagnosed as FMF in Upper Egypt, and to find the most common presenting symptoms.

* To mention the most common genetic variants reported in FMF patients in Upper Egypt, and to correlate the genetic variant with the risk to develop atherosclerosis.

* To assess the growth parameters in patients with FMF and compare it with the control group.

* To estimate the differences in Complete blood count (CBC) parameters, lipid profile, CIT in patients with FMF and control group.

* To search for subclinical atherosclerosis in patients with FMF based on their lipid profile and CIT.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Age at enrollment less than18 years.
  2. Both sexes.
  3. Diagnosed as familial Mediterranean fever according to Tel Hashomer criteria. [10]
Exclusion Criteria
  1. Patients with acute or chronic active infections.
  2. Patients with pre-existing illness as chronic lung, liver or renal diseases.
  3. Patients with diabetes mellitus, atherosclerotic vascular disease.
  4. Patients with malignancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
detecting subclinical atheroscelerosisIt will be measured in one year

The aim of this study is to detect subclinical

atherosclerosis in children diagnosed as FMF in Assiut University children's Hospital by measuring carotid intima thickness

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.